Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells

Stem Cells and Development

Volumn 18, Issue 4, 2009, Pages 661-670

  Dombrowski, Christian ^a   Song, Shu Jun ^a   Chuan, Peiying ^a   Lim, Xinhong ^a   Susanto, Evelyn ^c   Sawyer, Amber A ^a   Woodruff, Maria A ^c   Hutmacher, Dietmar W ^b,d   Nurcombe, Victor ^a,b   Cool, Simon M ^a,b  

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^b Department of Orthopaedic Surgery ^*  (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HEPARAN SULFATE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL CYCLE ARREST; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; MINERALIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; HEPARITIN SULFATE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RATS; RATS, WISTAR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SIGNAL TRANSDUCTION;

RATTUS;

EID: 67649243805     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0157     Document Type: Article

References (44)

1. Bianco P, M Riminucci, S Gronthos and PG Robey. (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192.
2. Stenderup K, J Justesen, EF Eriksen, SI Rattan and M Kassem. (2001). Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res 16:1120-1129.
3. Ling L, S Murali, C Dombrowski, LM Haupt, GS Stein, AJ van Wijnen, V Nurcombe and SM Cool. (2006). Sulfated glycosamin-oglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J Cell Physiol 209:811-825.
4. Hanada K, JE Dennis and AI Caplan. (1997). Stimulatory effects of basic fibroblast growth factor and bone morphogenetic pro-tein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12:1606-1614.
5. Chaudhary LR, AM Hofmeister and KA Hruska. (2004). Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 34:402-411.
6. Martin I, A Muraglia, G Campanile, R Cancedda and R Quarto. (1997). Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138:4456-4462.
7. Fisher MC, Y Li, MR Seghatoleslami, CN Dealy and RA Kosher. (2006). Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol 25:27-39.
8. Goodger SJ, CJ Robinson, KJ Murphy, N Gasiunas, NJ Harmer, TL Blundell, DA Pye and JT Gallagher. (2008). Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J Biol Chem 283:13001-13008.
9. Jackson RA, S Murali, AJ van Wijnen, GS Stein, V Nurcombe and SM Cool. (2007). Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J Cell Physiol 210:38-50.
10. Turnbull J, A Powell and S Guimond. (2001). Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 11:75-82.
11. Bernfield M, M Gotte, PW Park, O Reizes, ML Fitzgerald, J Lincecum and M Zako. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777.
12. Friedl A, Z Chang, A Tierney and AC Rapraeger. (1997). Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. Am J Pathol 150:1443-1455.
13. Chipperfield H, KS Bedi, SM Cool and V Nurcombe. (2002). Heparan sulfates isolated from adult neural progenitor cells can direct phenotypic maturation. Int J Dev Biol 46:661-670.
14. Nurcombe V, MD Ford, JA Wildschut and PF Bartlett. (1993). Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103-106.
15. Nurcombe V, CE Smart, H Chipperfield, SM Cool, B Boilly and H Hondermarck. (2000). The proliferative and migratory activities of breast cancer cells can be differentially regulated by heparan sulfates. J Biol Chem 275:30009-30018.
16. Small DH, G Reed, B Whitefield and V Nurcombe. (1995). Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture. J Neurosci 15:144-151.
17. Saksela O and DB Rifkin. (1990). Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 110:767-775.
18. Rapraeger AC, A Krufka and BB Olwin. (1991). Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myo-blast differentiation. Science 252:1705-1708.
19. Yayon A, M Klagsbrun, JD Esko, P Leder and DM Ornitz. (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848.
20. Globus RK, J Plouet and D Gospodarowicz. (1989). Culturedbovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124:1539-1547.
21. J ackson RA, V Nurcombe and SM Cool. (2006). Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 379:79-91.
22. Richardson TP, V Trinkaus-Randall and MA Nugent. (1999). Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate. J Biol Chem 274:13534-13540.
23. Ornitz DM and N Itoh. (2001). Fibroblast growth factors. Genome Biol 2:REVIEWS3005.
24. Shimoaka T, T Ogasawara, A Yonamine, D Chikazu, H Kawano, K Nakamura, N Itoh and H Kawaguchi. (2002). Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J Biol Chem 277:7493-7500.
25. Cool SM, CP Snyman, V Nurcombe and M Forwood. (2004). Temporal expression of fibroblast growth factor receptors during primary ligament repair. Knee Surg Sports Traumatol Arthrosc 12:490-496.
26. Zaragosi LE, G Ailhaud and C Dani. (2006). Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24:2412-2419.
27. Rider DA, C Dombrowski, AA Sawyer, GH Ng, D Leong, DW Hutmacher, V Nurcombe and SM Cool. (2008). Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells 26:1598-1608.
28. Pitaru S, S Kotev-Emeth, D Noff, S Kaffuler and N Savion. (1993). Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: enhanced development of mineralized bone-like tissue in culture. J Bone Miner Res 8:919-929.
29. Takada T, T Katagiri, M Ifuku, N Morimura, M Kobayashi, K Hasegawa, A Ogamo and R Kamijo. (2003). Sulfated polysac-charides enhance the biological activities of bone morphoge-netic proteins. J Biol Chem 278:43229-43235.
30. Jasuja R, BL Allen, WN Pappano, AC Rapraeger and DS Greenspan. (2004). Cell-surface heparan sulfate proteogly-cans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordin. J Biol Chem 279:51289-51297.
31. Wan M and X Cao. (2005). BMP signaling in skeletal development. Biochem Biophys Res Commun 328:651-657
32. Song SJ, D Hutmacher, V Nurcombe and SM Cool. (2006). Temporal expression of proteoglycans in the rat limb during bone healing. Gene 379:92-100.
33. Jacob AL, C Smith, J Partanen and DM Ornitz. (2006). Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 296:315-328.
34. Wu ZL, L Zhang, T Yabe, B Kuberan, DL Beeler, A Love and RD Rosenberg. (2003). The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J Biol Chem 278:17121-17129.
35. Chellaiah A, W Yuan, M Chellaiah and DM Ornitz. (1999). Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity. J Biol Chem 274:34785-34794.
36. Bonfini L, E Migliaccio, G Pelicci, L Lanfrancone and PG Pelicci. (1996). Not all Shc's roads lead to Ras. Trends Biochem Sci 21:257-261.
37. Jang JH. (2005). Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis. Oncogene 24:945-948.
38. Hoffman MP, BL Kidder, ZL Steinberg, S Lakhani, S Ho, HK Kleinman and M Larsen. (2002). Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP- and FGF- dependent mechanisms. Development 129:5767-5778.
39. Huang Z, ER Nelson, RL Smith and SB Goodman. (2007). The sequential expression profiles of growth factors from osteopro-genitors [correction of osteroprogenitors] to osteoblasts in vitro.Tissue Eng 13:2311-2320.
40. Quarto N and MT Longaker. (2006). FGF-2 inhibits osteogen-esis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12:1405-1418.
41. Zhao B, T Katagiri, H Toyoda, T Takada, T Yanai, T Fukuda, UI Chung, T Koike, K Takaoka and R Kamijo. (2006). Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem 281:23246-23253.
42. Nakashima K and B de Crombrugghe. (2003). Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19:458-466.
43. Celil AB and PG Campbell. (2005). BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280:31353-31359.
44. Woei Ng K, T Speicher, C Dombrowski, T Helledie, LM Haupt, V Nurcombe and SM Cool. (2007). Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors. Stem Cells Dev 16:305-318.